Fort Lauderdale, FL - November 17, 2009
OmniComm Systems, Inc., one of the fastest growing companies in the EDC marketplace, announced today that a leader in the medical device industry has selected OmniComm’s TrialMaster EDC solution for the data capture of a Phase IV cardiovascular study. The 24-months, 7-site study will enroll 100 subjects.
“We look forward to continuing our successful collaboration with this device company,” remarked Stephen Johnson, COO of OmniComm Systems. “Our flagship EDC solution, TrialMaster, has already proven to be an efficient and reliable data capture system for 12 of this customer’s studies during the past 5 years."
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.